| 1 |
34607938 | The Presence of Activated T Cell Subsets prior to Transplantation Is Associated with Increased Rejection Risk in Pancreas Transplant Recipients. | 2021 Nov 15 |
1 |
| 2 |
34668283 | Impact of immunosuppression on the immune response to SARS-CoV-2 infection: A mechanistic study. | 2021 Dec |
1 |
| 3 |
32268334 | Effect of Interleukin-2 Receptor Antibody Induction Therapy on Survival in Renal Transplant Patients Receiving Tacrolimus. | 2020 |
2 |
| 4 |
32749395 | Bioinspired β-glucan microcapsules deliver FK506 to lymph nodes for treatment of cardiac allograft acute rejection. | 2020 Oct 7 |
1 |
| 5 |
32932253 | Therapeutic and Immunoregulatory Effects of Tacrolimus in Patients with Refractory Generalized Myasthenia Gravis. | 2020 |
1 |
| 6 |
30472069 | Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients. | 2019 Feb |
3 |
| 7 |
30551354 | Tetramethylpyrazine (TMP) ameliorates corneal neovascularization via regulating cell infiltration into cornea after alkali burn. | 2019 Jan |
2 |
| 8 |
30729267 | IL-2 gene polymorphisms affect tacrolimus response in myasthenia gravis. | 2019 Jun |
4 |
| 9 |
30883749 | Targeted delivery of tacrolimus to T cells by pH-responsive aptamer-chitosan- poly(lactic-co-glycolic acid) nanocomplex. | 2019 Aug |
2 |
| 10 |
31321978 | Biosynthesis of Nonimmunosuppressive FK506 Analogues with Antifungal Activity. | 2019 Aug 23 |
1 |
| 11 |
31384453 | Implication of interleukin-2 receptor antibody induction therapy in standard risk renal transplant in the tacrolimus era: a meta-analysis. | 2019 Aug |
2 |
| 12 |
25817300 | Genetic association of interleukin-2, interleukin-4, interleukin-6, transforming growth factor-β, tumour necrosis factor-α and blood concentrations of calcineurin inhibitors in Turkish renal transplant patients. | 2015 Jun |
1 |
| 13 |
25883698 | Fungal infections in renal transplant patients. | 2015 Jun |
1 |
| 14 |
22447331 | Tacrolimus treatment increases bone formation in patients with rheumatoid arthritis. | 2013 Aug |
1 |
| 15 |
23743668 | Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus. | 2013 Aug |
4 |
| 16 |
24028719 | [Inhibitory effects of tacrolimus on effector T cells from patients with severe aplastic anemia]. | 2013 May 28 |
2 |
| 17 |
22974867 | Long-term interleukin-2 assessment after conversion from a twice-daily to once-daily tacrolimus regimen in stable kidney recipients. | 2012 Sep |
1 |
| 18 |
24175257 | Treatment of young patients with lupus nephritis using calcineurin inhibitors. | 2012 Dec 6 |
2 |
| 19 |
21176018 | Safety and efficacy of tacrolimus in pediatric liver recipients. | 2011 Feb |
1 |
| 20 |
21195813 | Clinical efficacy and immunological impact of tacrolimus in Chinese patients with generalized myasthenia gravis. | 2011 Apr |
1 |
| 21 |
21540458 | Calcineurin-dependent negative regulation of CD94/NKG2A expression on naive CD8+ T cells. | 2011 Jul 7 |
1 |
| 22 |
21620040 | Interleukin-2 profiles shortly after tacrolimus conversion from a twice-daily to once-daily regimen. | 2011 May |
1 |
| 23 |
21640771 | Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs. | 2011 Sep 25 |
1 |
| 24 |
20159692 | [Effect of FK506 on cytokine secretion in whole blood]. | 2010 Feb |
2 |
| 25 |
20233105 | Visual loss associated with tacrolimus: case report and review of the literature. | 2010 Jun |
1 |
| 26 |
20671192 | FK506 causes cellular and functional defects in human natural killer cells. | 2010 Dec |
1 |
| 27 |
19138532 | Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood. | 2009 Feb |
1 |
| 28 |
19628039 | Tacrolimus causes a blockage of protein secretion which reinforces its immunosuppressive activity and also explains some of its toxic side-effects. | 2009 Dec |
7 |
| 29 |
19930321 | In vitro cytokine responses in liver transplant recipients treated with cyclosporine A and tacrolimus. | 2009 Dec |
4 |
| 30 |
18465778 | Modulation of cytokine production by plant sterols in stimulated human Jurkat T cells. | 2008 Jun |
2 |
| 31 |
18570909 | [Today in molecular mechanisms of immunosuppressive drugs actions: roles of pharmacist]. | 2008 Mar |
1 |
| 32 |
17000002 | A humanized monoclonal antibody against interleukin-2 that can inactivate the cytokine/receptor complex. | 2007 Mar |
2 |
| 33 |
17523132 | Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51. | 2007 Jul |
2 |
| 34 |
17565322 | Interleukin-21: an interleukin-2 dependent player in rejection processes. | 2007 Jun 15 |
3 |
| 35 |
17594193 | Tacrolimus in the treatment of idiopathic nephrotic syndrome. | 2007 Jul |
1 |
| 36 |
17761346 | Mechanism of HDAC inhibitor FR235222-mediated IL-2 transcriptional repression in Jurkat cells. | 2007 Nov |
1 |
| 37 |
17880416 | Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells. | 2007 Oct |
2 |
| 38 |
16911492 | Tacrolimus immunosuppression - an association with asymptomatic eosinophilia and elevated total and specific IgE levels. | 2006 Sep |
2 |
| 39 |
17098001 | Variations in the frequency and type of infections in heart transplantation according to the immunosuppression regimen. | 2006 Oct |
1 |
| 40 |
17175263 | Paradoxical response to tacrolimus assessed by interleukin-2 gene expression. | 2006 Dec |
2 |
| 41 |
15716327 | Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1. | 2005 May |
1 |
| 42 |
16055081 | Zinc ions suppress mitogen-activated interleukin-2 production in Jurkat cells. | 2005 Sep 16 |
1 |
| 43 |
16378079 | The immunosuppressive agent FK506 enhances the cytolytic activity of inhibitory natural killer cell receptor (CD94/NKG2A)-expressing CD8 T cells. | 2005 Dec 27 |
2 |
| 44 |
16400900 | Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells. | 2005 Dec |
1 |
| 45 |
14709642 | Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect. | 2004 Jan |
4 |
| 46 |
15149578 | Newer Therapies for Inflammatory Bowel Disease. | 2004 Jun |
1 |
| 47 |
12548534 | Effects of FK506 on myasthenia gravis patients with high interleukin-2 productivity in peripheral blood mononuclear cells. | 2003 Feb |
1 |
| 48 |
12604780 | The FKBP-associated protein FAP48 is an antiproliferative molecule and a player in T cell activation that increases IL2 synthesis. | 2003 Mar 4 |
1 |
| 49 |
12835079 | The mosaic of immunosuppressive drugs. | 2003 Jul |
1 |
| 50 |
12942158 | Molecular actions of calcineurin inhibitors. | 2003 Jun |
2 |